偶氮二甲酸二甲酯, 99%

Methyl (NE)-N-methoxycarbonyliminocarbamate

(S)-(2S,3R)-3,4-二羟基丁-2-基 3-(4-(苄氧基)-苯基)-2-((叔-丁氧羰基)胺)丙酸酯, 98%

2-Methyl-2-propanyl _{(1S)-2-[4-(benzyloxy)phenyl]-1-[(2S)-2-oxiranyl]ethyl}carbamate

1,6-己二醇乙氧酸二丙烯酸酯, average Mn ~314, contains 300 ppm MEHQ as inhibitor

1,6-Hexanediol ethoxylate diacrylate

2-(2-氧代-1-咪唑烷基)乙基甲基丙烯酸酯, 98%

2-(2-Oxo-1-imidazolidinyl)ethyl Methacrylate

2-氯丙烯酸酯, contains >100 ppm MEHQ as inhibitor, 98%

2-Chloroethyl Acrylate

2-甲基-2-丙烯酸-2-(膦酰基氧基)乙酯, 98% ,stabilized with MEHQ

Ethyleneglycolmethacrylatephosphate

3-(3-溴-4-甲氧基苯基)丙烯酸, 98%

3-(3-Bromo-4-methoxyphenyl)acrylic acid

6-溴-1-己基丙烯酸酯, 98%

6-bromohexyl prop-2-enoate

PSS-(1-丙基异丁烯酸)-七异丁基取代, carbon：43.0 - 46.1 %

PSS-(1-Propylmethacrylate)-Heptaisobutyl substituted

三环 5.2.1.0 2,6 癸二酸二丙烯酸酯, mixture of isomers, stabilized with MEHQ

Tricyclo[5.2.1.0(2,6)]decanedimethanol diacrylate

乙二醇二环戊烯基醚丙烯酸酯, contains 700 ppm monomethyl ether hydroquinone as inhibitor

Ethylene glycol dicyclopentenyl ether acrylate

乙基 2-氰基-3-(二甲氨基)丙酸酯, 99%

Ethyl 2-Cyano-3-(dimethylamino)acrylate

(1-氟环己基)甲胺盐酸盐, 98%

(1-Fluorocyclohexyl)methanamine hydrochloride

(1-甲基-1H-吡唑-4-基)氨基甲酸叔丁酯, 98%

tert-Butyl (1-methyl-1H-pyrazol-4-yl)carbamate

(10-羧基癸基)(三苯基)溴化鏻, 98%

(10-Carboxydecyl)(triphenyl)phosphonium bromide

(1R,2S)-2-氧代螺[环丙烷-1,3-二氢吲哚]-2-羧酸乙酯, 98%

RAcemic-(1R,2S)-Ethyl 2-Oxospiro[Cyclopropane-1,3-Indoline]-2-Carboxylate

(1R,3R)-3-(((苄氧基)羰基)氨基)乙酸环己酯, 98%

(1R,3R)-3-(((Benzyloxy)carbonyl)amino)cyclohexyl acetate

(1R,3S)-3-(1,3-二氧异吲哚啉-2-基)环己基乙酸酯, 98%

(1R,3S)-3-(1,3-Dioxoisoindolin-2-yl)cyclohexyl acetate

(1R,4R)-5-氧代-2-氮杂双环[2.2.1]庚烷-2-羧酸苄酯, 98%

(1R,4R)-Benzyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate

(1R,4R,5R)-2-氮杂双环[2.2.1]庚烷-5-基氨基甲酸叔丁酯, 98%

tert-Butyl (1R,4R,5R)-2-azabicyclo[2.2.1]heptan-5-ylcarbamate